These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 4574399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transfer factor therapy in immunodeficiency.
    Griscelli C.
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transfer factor therapy in immuno-deficiencies.
    Griscelli C, Revillard JP, Betuel H, Herzog C, Touraine JL.
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell-mediated immunity.
    Valentine FT, Lawrence HS.
    Adv Intern Med; 1971 May; 17():51-93. PubMed ID: 4147307
    [No Abstract] [Full Text] [Related]

  • 7. [Cellular and humoral defense. Significance in hematology and immunopathology].
    Tilz GP.
    Med Klin; 1972 Mar 10; 67(10):341-5. PubMed ID: 5063220
    [No Abstract] [Full Text] [Related]

  • 8. [Transfer factor and its therapeutic use].
    Rosenthal M.
    Schweiz Med Wochenschr; 1974 Oct 26; 104(43):1501-6. PubMed ID: 4549135
    [No Abstract] [Full Text] [Related]

  • 9. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH, Rich RR, Smith TK.
    J Clin Invest; 1972 Nov 26; 51(11):2948-58. PubMed ID: 5080419
    [Abstract] [Full Text] [Related]

  • 10. Transfer factor.
    Lawrence HS.
    Adv Immunol; 1969 Nov 26; 11():195-266. PubMed ID: 4910774
    [No Abstract] [Full Text] [Related]

  • 11. [Transfer factor and its therapeutic significance].
    Hitzig WH.
    Blut; 1973 Sep 26; 27(3):145-50. PubMed ID: 4206332
    [No Abstract] [Full Text] [Related]

  • 12. [Transfer factor. Immunologic basis and therapeutic experience].
    Hitzig WH, Fontanellaz HP, Müntener U, Paul S, Spitler LE, Fudenberg HH.
    Schweiz Med Wochenschr; 1972 Sep 02; 102(35):1237-44. PubMed ID: 5054632
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z.
    Pediatr Pol; 1975 Nov 02; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract] [Full Text] [Related]

  • 14. Immunodeficiency states.
    Lessof MH.
    Proc R Soc Med; 1974 Jun 02; 67(6 Pt 2):530-6. PubMed ID: 4368789
    [No Abstract] [Full Text] [Related]

  • 15. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP.
    Immunology; 1979 Jan 02; 36(1):1-12. PubMed ID: 369991
    [Abstract] [Full Text] [Related]

  • 16. 'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.
    Han T.
    Clin Exp Immunol; 1973 Jun 02; 14(2):213-7. PubMed ID: 4717914
    [Abstract] [Full Text] [Related]

  • 17. Transfer factor in cellular immunity.
    Lawrence HS.
    Harvey Lect; 1974 Jun 02; 68():239-350. PubMed ID: 4616018
    [No Abstract] [Full Text] [Related]

  • 18. Biologic and clinical implications of transfer factor.
    Mutz I, Lankford J, Humphrey GB.
    South Med J; 1974 Jul 02; 67(7):837-40. PubMed ID: 4599982
    [No Abstract] [Full Text] [Related]

  • 19. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE, Levin AS, Stites DP, Fudenberg HH, Pirofsky B, August CS, Stiehm ER, Hitzig WH, Gatti RA.
    J Clin Invest; 1972 Dec 02; 51(12):3216-24. PubMed ID: 4640955
    [Abstract] [Full Text] [Related]

  • 20. Uses of transfer factor.
    Basten A, Croft S, Kenny DF, Nelson DS.
    Vox Sang; 1975 Dec 02; 28(4):257-77. PubMed ID: 804764
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.